ReP USP - Resultado da busca

Artigo de periodico
Fluoxetine versus trimipramine in the treatment of depression in geriatric patients (2005)
Welmeier, P. M.; Kluge, M.; Maras, A.; Riemann, D.; Berger, M.; Kohnen, R.; Dittmann, R. W.; Gattaz, W. F.
Source: Pharmacopsychiatry. Unidade: FM
Subjects: DEPRESSÃO (TERAPIA), ANTIDEPRESSIVOS (APLICAÇÕES TERAPÊUTICAS), SEROTONINA (ANTAGONISTAS E INIBIDORES), IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELMEIER, P. M. et al. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry, v. 38, p. 13-16, 2005Tradução . . Acesso em: 13 nov. 2024.
APA
Welmeier, P. M., Kluge, M., Maras, A., Riemann, D., Berger, M., Kohnen, R., et al. (2005). Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry, 38, 13-16.
NLM
Welmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry. 2005 ; 38 13-16.[citado 2024 nov. 13 ]
Vancouver
Welmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry. 2005 ; 38 13-16.[citado 2024 nov. 13 ]
Artigo de periodico
Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia:: a randomized double-blind trial (2004)
Gattaz, Wagner Farid; Diehl, A.; Geuppert, M. S.; Hubrich, P.; Schmitt, A.; Maras, A.; Dittmann, R. W.
Source: Pharmacopsychiatry. Unidade: FM
Subjects: ESQUIZOFRENIA (TERAPIA), MÉTODO DUPLO-CEGO, ANTIPSICÓTICOS (APLICAÇÕES TERAPÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GATTAZ, Wagner Farid et al. Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia:: a randomized double-blind trial. Pharmacopsychiatry, v. 37, p. 279-285, 2004Tradução . . Acesso em: 13 nov. 2024.
APA
Gattaz, W. F., Diehl, A., Geuppert, M. S., Hubrich, P., Schmitt, A., Maras, A., & Dittmann, R. W. (2004). Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia:: a randomized double-blind trial. Pharmacopsychiatry, 37, 279-285.
NLM
Gattaz WF, Diehl A, Geuppert MS, Hubrich P, Schmitt A, Maras A, Dittmann RW. Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia:: a randomized double-blind trial. Pharmacopsychiatry. 2004 ; 37 279-285.[citado 2024 nov. 13 ]
Vancouver
Gattaz WF, Diehl A, Geuppert MS, Hubrich P, Schmitt A, Maras A, Dittmann RW. Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia:: a randomized double-blind trial. Pharmacopsychiatry. 2004 ; 37 279-285.[citado 2024 nov. 13 ]
Artigo de periodico
Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia (2001)
Schmitt, A.; Maras, A.; Petroianu, G.; Braus, D. F.; Scheuer, L.; Gattaz, Wagner Farid
Source: Journal of Neural Transmission. Unidade: FM
Assunto: ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHMITT, A. et al. Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia. Journal of Neural Transmission, v. 108, n. 8-9, p. 1081-1091, 2001Tradução . . Disponível em: https://doi.org/10.1007/s007020170026. Acesso em: 13 nov. 2024.
APA
Schmitt, A., Maras, A., Petroianu, G., Braus, D. F., Scheuer, L., & Gattaz, W. F. (2001). Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia. Journal of Neural Transmission, 108( 8-9), 1081-1091. doi:10.1007/s007020170026
NLM
Schmitt A, Maras A, Petroianu G, Braus DF, Scheuer L, Gattaz WF. Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia [Internet]. Journal of Neural Transmission. 2001 ; 108( 8-9): 1081-1091.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s007020170026
Vancouver
Schmitt A, Maras A, Petroianu G, Braus DF, Scheuer L, Gattaz WF. Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia [Internet]. Journal of Neural Transmission. 2001 ; 108( 8-9): 1081-1091.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s007020170026
Trabalho de evento-resumo
Die Wirkung von Haloperidol und Zotepin auf den Phospholipid - Metabolismus bei der Schizophrenie (2001)
Schmitt, A.; Maras, A.; Braus, D. F.; Tost, H.; Jatzko, A.; Gattaz, W. F.
Source: Nervenheiilkunde. Conference titles: Deutsche Gesellschaft für Psychiatrie, Psychoterapie und Nervenheilkunde. Unidade: FM
Assunto: ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHMITT, A. et al. Die Wirkung von Haloperidol und Zotepin auf den Phospholipid - Metabolismus bei der Schizophrenie. 2001, Anais.. Berlim: Faculdade de Medicina, Universidade de São Paulo, 2001. p. S132. . Acesso em: 13 nov. 2024.
APA
Schmitt, A., Maras, A., Braus, D. F., Tost, H., Jatzko, A., & Gattaz, W. F. (2001). Die Wirkung von Haloperidol und Zotepin auf den Phospholipid - Metabolismus bei der Schizophrenie. In Nervenheiilkunde (Vol. 20, p. S132). Berlim: Faculdade de Medicina, Universidade de São Paulo.
NLM
Schmitt A, Maras A, Braus DF, Tost H, Jatzko A, Gattaz WF. Die Wirkung von Haloperidol und Zotepin auf den Phospholipid - Metabolismus bei der Schizophrenie. Nervenheiilkunde. 2001 ; 20 S132.[citado 2024 nov. 13 ]
Vancouver
Schmitt A, Maras A, Braus DF, Tost H, Jatzko A, Gattaz WF. Die Wirkung von Haloperidol und Zotepin auf den Phospholipid - Metabolismus bei der Schizophrenie. Nervenheiilkunde. 2001 ; 20 S132.[citado 2024 nov. 13 ]
Artigo de periodico
Antipsychotika und Phospholipidmetabolismus bei der Schizophrenie (2001)
Schmitt, A.; Gattaz, Wagner Farid; Maras, A.; Braus, D. F.; Petroianu, G.; Jatzko, A.
Source: Fortschritte der Neurologie - Psychiatrie. Unidade: FM
Subjects: ANTIPSICÓTICOS, NEUROLOGIA, PSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHMITT, A. et al. Antipsychotika und Phospholipidmetabolismus bei der Schizophrenie. Fortschritte der Neurologie - Psychiatrie, v. 69, p. 503-509, 2001Tradução . . Disponível em: https://doi.org/10.1055/s-2001-18379. Acesso em: 13 nov. 2024.
APA
Schmitt, A., Gattaz, W. F., Maras, A., Braus, D. F., Petroianu, G., & Jatzko, A. (2001). Antipsychotika und Phospholipidmetabolismus bei der Schizophrenie. Fortschritte der Neurologie - Psychiatrie, 69, 503-509. doi:10.1055/s-2001-18379
NLM
Schmitt A, Gattaz WF, Maras A, Braus DF, Petroianu G, Jatzko A. Antipsychotika und Phospholipidmetabolismus bei der Schizophrenie [Internet]. Fortschritte der Neurologie - Psychiatrie. 2001 ; 69 503-509.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1055/s-2001-18379
Vancouver
Schmitt A, Gattaz WF, Maras A, Braus DF, Petroianu G, Jatzko A. Antipsychotika und Phospholipidmetabolismus bei der Schizophrenie [Internet]. Fortschritte der Neurologie - Psychiatrie. 2001 ; 69 503-509.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1055/s-2001-18379
Trabalho de evento-resumo
Effects of haloperidol and zotepine treatment on the phospholipid metabolism in schizophrenia (2001)
Schmitt, A.; Maras, A.; Braus, D. F.; Tost, H.; Jatzko, A.; Gattaz, W. F.
Source: Nervenheiilkunde. Conference titles: Deutsche Gesellschaft für Psychiatrie, Psychoterapie und Nervenheilkunde. Unidade: FM
Assunto: ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHMITT, A. et al. Effects of haloperidol and zotepine treatment on the phospholipid metabolism in schizophrenia. 2001, Anais.. Berlim: Faculdade de Medicina, Universidade de São Paulo, 2001. . Acesso em: 13 nov. 2024.
APA
Schmitt, A., Maras, A., Braus, D. F., Tost, H., Jatzko, A., & Gattaz, W. F. (2001). Effects of haloperidol and zotepine treatment on the phospholipid metabolism in schizophrenia. In Nervenheiilkunde (Vol. 20). Berlim: Faculdade de Medicina, Universidade de São Paulo.
NLM
Schmitt A, Maras A, Braus DF, Tost H, Jatzko A, Gattaz WF. Effects of haloperidol and zotepine treatment on the phospholipid metabolism in schizophrenia. Nervenheiilkunde. 2001 ; 20[citado 2024 nov. 13 ]
Vancouver
Schmitt A, Maras A, Braus DF, Tost H, Jatzko A, Gattaz WF. Effects of haloperidol and zotepine treatment on the phospholipid metabolism in schizophrenia. Nervenheiilkunde. 2001 ; 20[citado 2024 nov. 13 ]
Trabalho de evento
Olanzapine versus flupentixole in the treatment of inpatients with schizophrenia: a randomized double-blind trial (2001)
Dittmann, R. W.; Geuppert, M. S.; Diehl, A.; Hubrich, P.; Maras, A.; Gattaz, Wagner Farid
Conference titles: International Congress on Schizophrenia Research. Unidade: FM
Subjects: ESQUIZOFRENIA, PSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DITTMANN, R. W. et al. Olanzapine versus flupentixole in the treatment of inpatients with schizophrenia: a randomized double-blind trial. 2001, Anais.. Whistler: Faculdade de Medicina, Universidade de São Paulo, 2001. . Acesso em: 13 nov. 2024.
APA
Dittmann, R. W., Geuppert, M. S., Diehl, A., Hubrich, P., Maras, A., & Gattaz, W. F. (2001). Olanzapine versus flupentixole in the treatment of inpatients with schizophrenia: a randomized double-blind trial. In . Whistler: Faculdade de Medicina, Universidade de São Paulo.
NLM
Dittmann RW, Geuppert MS, Diehl A, Hubrich P, Maras A, Gattaz WF. Olanzapine versus flupentixole in the treatment of inpatients with schizophrenia: a randomized double-blind trial. 2001 ;[citado 2024 nov. 13 ]
Vancouver
Dittmann RW, Geuppert MS, Diehl A, Hubrich P, Maras A, Gattaz WF. Olanzapine versus flupentixole in the treatment of inpatients with schizophrenia: a randomized double-blind trial. 2001 ;[citado 2024 nov. 13 ]
Artigo de periodico
Effects of beta-amyloid peptides on the fluidity of membranes form frontal and parietal lobes of human brain: high potencies of Abeta1-42 and Abeta1-43 (1998)
Müller, W. E.; Eckert, G. P.; Scheuer, K.; Cairns, N. J.; Maras, A.; Gattaz, Wagner Farid
Source: Amyloid : The International Journal of Experimental and Clinical Investigation. Unidade: FM
Subjects: PSIQUIATRIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MÜLLER, W. E. et al. Effects of beta-amyloid peptides on the fluidity of membranes form frontal and parietal lobes of human brain: high potencies of Abeta1-42 and Abeta1-43. Amyloid : The International Journal of Experimental and Clinical Investigation, v. 5, p. 10-15, 1998Tradução . . Acesso em: 13 nov. 2024.
APA
Müller, W. E., Eckert, G. P., Scheuer, K., Cairns, N. J., Maras, A., & Gattaz, W. F. (1998). Effects of beta-amyloid peptides on the fluidity of membranes form frontal and parietal lobes of human brain: high potencies of Abeta1-42 and Abeta1-43. Amyloid : The International Journal of Experimental and Clinical Investigation, 5, 10-15.
NLM
Müller WE, Eckert GP, Scheuer K, Cairns NJ, Maras A, Gattaz WF. Effects of beta-amyloid peptides on the fluidity of membranes form frontal and parietal lobes of human brain: high potencies of Abeta1-42 and Abeta1-43. Amyloid : The International Journal of Experimental and Clinical Investigation. 1998 ; 5 10-15.[citado 2024 nov. 13 ]
Vancouver
Müller WE, Eckert GP, Scheuer K, Cairns NJ, Maras A, Gattaz WF. Effects of beta-amyloid peptides on the fluidity of membranes form frontal and parietal lobes of human brain: high potencies of Abeta1-42 and Abeta1-43. Amyloid : The International Journal of Experimental and Clinical Investigation. 1998 ; 5 10-15.[citado 2024 nov. 13 ]

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Non normalized affiliation